NSE · VCL
Vaxtex Cotfab Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹6 Cr with net profit ₹1 Cr — a 13.84% net margin, versus -51.78% the period before.
Shareholding
As of 2026-06-30
- Promoter0.5%
- Public88.36%
- FII11.14%
39,842 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 3.06× from low to high.
Risk flags
Derived from disclosed data
- Under exchange surveillance — ESM · ESM 1. Trading may carry price bands, periodic call auction or higher margins.
Peer comparison
Textile Manufacturing · ranked #25 of 28 by market cap · medians across 27 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| GHCL Textiles Limited | ₹1,267 Cr | 13.17 | 0.84 | 4.68% | 6.59% |
| Nahar Spinning Mills Ltd. | ₹977 Cr | 12.79 | 0.65 | 1.44% | 2.25% |
| Ambika Cotton Mill Ltd. | ₹920 Cr | 11.31 | 0.96 | 7.5% | 9.6% |
| Borana Weaves Limited | ₹846 Cr | 12.28 | 3 | 22.95% | 16.87% |
| Cheviot Company Limited | ₹699 Cr | 10.23 | 0.99 | 7.32% | 11.41% |
| Pasupati Acrylon Limited | ₹604 Cr | 6.29 | 1.38 | 16.06% | 9.26% |
| Manomay Tex India Ltd. | ₹424 Cr | 21.04 | 2.48 | 11.49% | 2.71% |
| Thomas Scott (India) Ltd. | ₹362 Cr | 16.35 | 2.55 | 14.06% | 7.93% |
| Ginnifilaments Ltd. | ₹354 Cr | 10.02 | 1.52 | 19.08% | 9.39% |
| Bella Casa Fash And Ret Limited | ₹351 Cr | 19.53 | 2.07 | 12.05% | 4.03% |
| Vaxtex Cotfab Limited(this company) | ₹32 Cr | 5.97 | 1.42 | 24.62% | 47.09% |
AI analysis
AI-generated · google/gemini-2.5-flashVaxtex Cotfab Limited is listed with a market capitalization of Rs 20 Cr. The company reported revenue of Rs 6.38 Cr and a profit margin of 49.51%. Its Price-to-Earnings ratio is 3.67, with an EPS of 0.3. The latest promoter holding as of March 31, 2026, is 0.5013%.
Positives
- +The company has a positive profit margin of 49.51% for the latest reported annual period.
- +The Return on Equity (ROE) is 24.62%, indicating profitability relative to shareholders' equity.
- +The Return on Capital Employed (ROCE) is 18.53%, showing efficiency in using capital.
- +The debt-to-equity ratio is 0.61, indicating a moderate level of debt.
Negatives
- −Promoter holding has significantly decreased from 67.8152% in June 2022 to 0.5013% in March 2026.
- −Revenue declined from Rs 76.51 Cr in March 2023 to Rs 6.38 Cr in March 2025.
- −The company reported a net loss of Rs -8.83 Cr in March 2024.
- −Quarterly revenue for December 2024 and March 2026 was reported as Rs 0 Cr.
Financial performance
Vaxtex Cotfab Limited's revenue experienced significant fluctuations. Revenue decreased from Rs 76.51 Cr in March 2023 to Rs 17.06 Cr in March 2024, continuing its decline to Rs 6.38 Cr in March 2025. Net profit also saw variations, moving from Rs 1.13 Cr in March 2023 to a net loss of Rs -8.83 Cr in March 2024, before recovering to a net profit of Rs 0.88 Cr in March 2025.
Profitability & returns
The company's profitability, as measured by return on equity (ROE), is 24.62%, and return on capital employed (ROCE) is 18.53%. The profit margin for the latest annual period is 49.51%. The EPS has shown volatility, decreasing from Rs 0.11 in March 2023 to Rs -0.556 in March 2024, and then increasing to Rs 0.048 in March 2025.
Balance sheet
The debt-to-equity ratio of Vaxtex Cotfab Limited is 0.61. The book value per share is Rs 1.22. No dividend yield was reported.
Ownership & pledges
Public shareholding stands at 88.3065%. The company has no reported promoter share pledges.
Regulatory & surveillance
The company is not currently under any reported surveillance measures. There are no reported pledges by promoters.
Data as of — price: 2026-09-11 · financials: Mar 25 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.